Benicar and Ipf - a phase IV clinical study of FDA data

Summary:

Ipf is reported as a side effect among people who take Benicar (olmesartan medoxomil), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Synthroid, and have Neoplasm malignant.

The phase IV clinical study analyzes which people have Ipf when taking Benicar. It is created by eHealthMe based on reports of 34,073 people who have side effects when taking Benicar from the FDA, and is updated regularly.

What is Benicar?

Benicar has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 36,002 Benicar users. Check the latest studies of Benicar.

What is Ipf?

Ipf is found to be associated with 1,841 drugs and 2,257 conditions by eHealthMe. Check the latest studies of Ipf.

On Jan, 11, 2026

34,073 people reported to have side effects when taking Benicar.
Among them, 33 people (0.1%) have Ipf.

Among these 33 people:

How long have people been on Benicar when they have Ipf? *

What is the gender of people who have Ipf when taking Benicar? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Ipf when taking Benicar? *

What are other drugs people take besides Benicar? *

Norvasc: 13 people, 39.39%
Synthroid: 13 people, 39.39%
Glipizide: 11 people, 33.33%
Meperidine Hydrochloride: 10 people, 30.30%
Sutent: 10 people, 30.30%
Glycopyrrolate: 10 people, 30.30%
Glucotrol: 10 people, 30.30%
Ondansetron: 10 people, 30.30%
Fluoxetine: 10 people, 30.30%
Pioglitazone: 10 people, 30.30%

What are other side effects people have besides Ipf? *

Diarrhea: 20 people, 60.61%
Nausea (feeling of having an urge to vomit): 19 people, 57.58%
Sinusitis (inflammation of sinus): 17 people, 51.52%
Dehydration (dryness resulting from the removal of water): 16 people, 48.48%
Fatigue (feeling of tiredness): 16 people, 48.48%
Pleural Effusion (water on the lungs): 15 people, 45.45%
Headache (pain in head): 15 people, 45.45%
Stress And Anxiety: 14 people, 42.42%
Insomnia (sleeplessness): 14 people, 42.42%
Nausea And Vomiting: 14 people, 42.42%

What are the existing conditions these people have? *

Neoplasm Malignant (cancer tumour): 10 people, 30.30%
Osteoporosis (bones weak and more likely to break): 5 people, 15.15%
Immunodeficiency Disorders: 4 people, 12.12%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 12.12%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 9.09%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 9.09%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 2 people, 6.06%
Hair Loss: 2 people, 6.06%
Asthma: 1 person, 3.03%
Bone Disorder: 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Benicar and have Ipf?

- Check whether Ipf is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Benicar:

Benicar (36,002 reports)

Ipf treatments and more:

Ipf (79,193 reports)

Browse all side effects of Benicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ipf:

Ipf (1,841 drugs)

Browse all the conditions that are associated with Ipf:

Ipf (2,257 conditions)

Drugs similar to Benicar and Ipf :

How the study uses the data?

The study uses data from the FDA. It is based on olmesartan medoxomil (the active ingredients of Benicar) and Benicar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.